 |
answer text |
<p>Data about fortifying and non-fortifying countries is not extensive and does not
identify fortifiers and non-fortifiers in a meaningful way. As a result we do not
have comparable data for prevalence of births with neural tube defects (NTDs) across
the European Union or with North America pre and post fortification. Available data
on prevalence is in the public domain and is listed below:</p><table><tbody><tr><td
colspan="2"><p>Prevalence of NTD per 10,000 births for those EU members states where
figures are available</p></td></tr><tr><td><p>United Kingdom</p></td><td><p>12.8</p></td></tr><tr><td><p>Belgium
8</p></td><td><p>8.54</p></td></tr><tr><td><p>Croatia</p></td><td><p>4.64</p></td></tr><tr><td><p>Denmark</p></td><td><p>11.24</p></td></tr><tr><td><p>France</p></td><td><p>12.70</p></td></tr><tr><td><p>Germany</p></td><td><p>11.00</p></td></tr><tr><td><p>Ireland</p></td><td><p>8.19</p></td></tr><tr><td><p>Italy</p></td><td><p>5.36</p></td></tr><tr><td><p>Netherlands</p></td><td><p>6.71</p></td></tr><tr><td><p>Poland</p></td><td><p>10.14</p></td></tr><tr><td><p>Portugal</p></td><td><p>4.27</p></td></tr><tr><td><p>Spain</p></td><td><p>9.55</p></td></tr></tbody></table><br
/><p><em>Source:</em> EUROCAT Special Report: Prevalence of Neural Tube Defects in
younger mothers in Europe 20002008. EUROCAT (2010)</p><br /><table><tbody><tr><td><p>United
States</p></td><td><p>6.5</p></td></tr></tbody></table><br /><p><em>Source:</em> Centers
for Disease Control and Prevention (CDC). Updated Estimates of Neural Tube Defects
Prevented by Mandatory Folic Acid Fortification — United States, 1995–2011. Morbidity
and Mortality Weekly Report. 2015; 64: 1-5.</p><br />
|
|
